SCHERING-PLOUGH: Temodar Patent Infringement Suit Still Pending
August 8, 2008
Schering-Plough Corp.’s patent infringement action against companies seeking approval of a generic version of certain strengths of Temodar capsules is still pending.
The Company and its licensor, Cancer Research Technologies, Limited,…